ESC 365 - Impact of a novel lesion target on clinical outcome of paroxysmal atrial fibrillation ablation.

EHRA Premium Access

Impact of a novel lesion target on clinical outcome of paroxysmal atrial fibrillation ablation.

Session: Atrial fibrillation ablation - New tools and strategies for lesion creation and evaluation

Topic: Catheter Ablation of Arrhythmias

Speaker: Doctor E. De Ruvo (Rome, IT)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Doctor Ermenegildo De Ruvo

Polyclinic Casilino, Rome (Italy)

0 follower

8 more presentations in this session

Cryoballoon ablation in early persistent atrial fibrillation patients: single procedure outcomes following pulmonary vein isolation in the prospective multicenter CRYO4PERSISTENT AF Study

Speaker: Doctor S. Boveda (Toulouse, FR)

Real-time gap detection during atrial fibrillation ablation using novel dielectric sensing system: results of the Durable-I clinical trial

Speaker: Doctor A. Romanov (Novosibirsk, RU)

The lesion width and gap assessed by late-gadolinium enhancement magnetic resonance imaging after hotballoon ablation as compared to cryoballoon and conventional radiofrequency ablation .

Speaker: Doctor T. Akita (Ono, JP)

Reproducible and semi-automatic method for the assessment of ablation gaps in LGE-CMR after RF pulmonary vein isolation

Speaker: Doctor O. Camara-Rey (Barcelona, ES)

Optical coherence tomography as a tool for radiofrequency ablation lesion assessment - proof of concept

Speaker: Doctor A. Haeberlin (Bern, CH)

Access the full session

Atrial fibrillation ablation - New tools and strategies for lesion creation and evaluation

Speakers: Doctor E. De Ruvo, Doctor S. Boveda, Doctor A. Romanov, Doctor T. Akita, Doctor O. Camara-Rey...

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources